Arizona Tribune - Boulevard

NYSE - LSE

CMSC	0.15%	20.27	$
RYCEF	1.92%	19.8	$
RBGPF	-3.48%	62.9	$
VOD	-0.18%	16.79	$
NGG	-0.13%	76.02	$
RIO	1.51%	95.65	$
GSK	-1.03%	46.55	$
BTI	0.45%	52.88	$
BCE	0.05%	19.74	$
BCC	-0.2%	74.84	$
RELX	1.18%	33.82	$
BP	-0.38%	44.62	$
AZN	-0.24%	156.53	$
JRI	-2.35%	10.65	$
CMSD	0%	20.43	$

Featured

'Eats through a straw': French teens wounded in high school protests

Several children have been seriously injured during protests in France, as high school pupils demand better conditions and police crack down on their demonstrations.

Purple reign: Philippines seeks to keep grip on ube throne

The Philippine ube has become a trend-setting sensation from Los Angeles to London to Seoul, with the humble yam's bright purple hue drawing lines outside coffee shops and bakeries and millions of views on social media.

Last news

'Hell': Father of surfers killed in Mexico testifies at trial

The father of two Australian surfers killed in Mexico two years ago testified in court Tuesday that his life had been turned into hell, as the high-profile trial continued into its second day.

Marijuana Schedule III Escapes an Immediate Freeze-Now the Billion-Dollar Order Must Survive the Law

"The federal appeals court left the limited Schedule III order in effect while MMJ's challenge proceeds, but the stay denial did not uphold the order's legality or decide the separate DEA proceeding considering broader marijuana rescheduling." - Duane Boise, President, MMJ International Holdings

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds

KELOWNA, BC / ACCESS Newswire / September 9, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today closed its previously announced exercise of certain outstanding warrants to purchase an aggregate of 453,969 shares of the Company's common stock originally issued by the Company on February 16, 2024, having an original exercise price of $32.78 per share, on October 16, 2024, having an original exercise price of $45.90 per share, on September 29, 2025, having an original exercise price of $20.55 per share and on December 16, 2025, having an original exercise price of $17.85 per share, at a reduced exercise price of $12.92 per share.

BetterWay(TM) Blood Testing Shows How U.S. Logistics Can Help Expand Access to Healthcare at Made in America Summit

Pairing sophisticated logistics with patient-friendly fingertip collection without phlebotomists could reduce non-adherence to routine testing

Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market

First orders received for the Company's veterinary antimicrobial line, which will be marketed under the brand name C-ScrubVetFormulated for dogs, cats, horses, companion and large animals, and supplied in a 500ml pump-dispenser bottleSales have commenced in the United Kingdom, with additional European markets to follow from Q4 2026Multichannel strategy initially focused on e-commerce, with planned expansion into pet store chains and veterinary clinicsCertified under European standards EN 1656 and EN 1657 for bactericidal and fungicidal activity in veterinary useManufactured in-house at Cana Laboratories' EU GMP-licensed, EMA-certified facility, consistent with the Company's vertically integrated modelExtends the C-Scrub franchise beyond human healthcare, addressing the $69 billion global animal health marketExpected to be one of several catalysts supporting the Company's previously issued 2029 guidance of $200.6 million in revenue, $44.2 million in adjusted EBITDA and $31 million in net income

Robinson+Cole Supports Asia-U.S. Capital Markets and Cross-Border Growth as Gold Sponsor of Japan Go IPO Summit 2026

Firm reinforces commitment to capital formation, international business growth, and the Asia-U.S. business community through participation in premier industry event

Global Study: Nursing Shortages Require Workforce Policy Solutions, Not Recruitment Campaigns Alone

Why people choose nursing, and why they leave, comes down to the same factors

Medical Care Technologies Inc. (OTCID:MDCE) Moves StrainScan Pro Forward as Initial Agricultural Demos Validate Platform Capabilities

Early Enterprise Sessions Confirm Strong Operator Interest and Are Now Guiding the Next Build-Out of the Platform

CPG Life Fund I Retains Fast Moving Consumer Goods (OTC: GGII) as Strategic Advisor

The $20 million operator-led consumer fund has named Fast Moving Consumer Goods, Inc. as its CPG fund strategic advisor for deal sourcing, brand evaluation, commercialization, and portfolio operations.

Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program

Brings total authorized repurchase to $10 millionReflects leadership's view that Aspire-Lakewood's share price does not reflect the Company's financial strength or long-term growth opportunityIncreased authorization supported by strength of newly acquired Dura Control Systems Corp's (DCSC) full year 2025 and six months ended June 30, 2026 revenue of approximately $209.5 million and Adjusted EBITDA1 of $22.3 million and approximately $103.9 million and Adjusted EBITDA1 of $10.5 million, respectively

MDelite Introduces Eleo IPL on the iProElite Platform, Advancing Energy Delivery with Non-Contact Cooling

Eleo IPL combines non-contact cooling, ultra-short pulses and a BK7 optical tip with a lightweight handpiece in a system that requires no water cooling.

Dalet Appoints Brian Doheny as Chief Executive Officer

NEW YORK CITY, NY / ACCESS Newswire / September 9, 2026 / Dalet, a leading technology and service provider for media-rich organizations, today announced the appointment of Brian Doheny as Chief Executive Officer (CEO). Doheny joined Dalet as President and Chief Revenue Officer in April 2026. Since joining Dalet, Doheny has led the company's Go-to-Market and Customer Experience organizations, working across the business to bring greater alignment around customer needs and accelerate the delivery of solutions that address their operational priorities.

374Water Unveils Strategy to Scale AirSCWO into a Global Waste Destruction Platform

Company targets recurring Waste Destruction Services revenue, regional biosolids infrastructure and global expansion through licensing and strategic partnerships

FLY REBEL FLY: American Rebel Light Beer Launches Abraham Lincoln "Be a Rebel" Campaign Ahead of Philadelphia Eagles Home Opener

From Lincoln to The Linc, America's Patriotic Beer Builds on Pennsylvania Momentum and Prepares for Its First Regular-Season NFL Game-Day ServiceLatest "Historic Moments" Video Featuring Abraham Lincoln and American Rebel CEO Andy Ross is Now Featured on AmericanRebel.com Days Before Philadelphia's September 13 NFL Home Opener

Wi2Wi Announces US$2.6 Million Three-Year Contract with a Confidential Defense Organization, Stock Option Grant, and Investor Relations Engagement

MIDDLETON, WI / ACCESS Newswire / September 9, 2026 / Wi2Wi Corporation ("Wi2Wi" or the "Company") (TSXV:YTY) announces that it has entered into a three-year contract, valued at US$2.6 million, with a confidential defense organization for Precision Devices products for an aerospace application. The Company also announces the grant of 2.1 million stock options to officers and directors at an exercise price of $0.075 per stock option, and an investor relations engagement with Boardmarker Group, subject to TSX Venture Exchange approval.

Organto Foods to Participate in Fruit Attraction 2026 Conference in Madrid, Spain

VANCOUVER, BC, AND BREDA, THE NETHERLANDS / ACCESS Newswire / September 9, 2026 / Organto Foods Inc. (TSXV:OGO)(OTCQX:OGOFF)(FSE:OGF0) ("Organto" or "the Company"), is pleased to announce its participation in Fruit Attraction 2026 being held in Madrid, Spain and taking place from October 6th to October 8th.

Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue

September session to spotlight how Zomedica's marketing function creates demand, equips the field, and supports utilization across the company's diagnostic and therapeutic portfolios

InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 09

LONDON, UK / ACCESS Newswire / September 9, 2026 / The Company announces that on 08 September 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

Hong Kong's first post-colonial leader Tung Chee-hwa dies aged 89

Hong Kong's first post-colonial leader Tung Chee-hwa has died aged 89, his office said Wednesday.

NY failed to disclose what it knew on 'toxic air' after 9/11

New York Mayor Zohran Mamdani announced on Tuesday the release of tens of thousands of documents showing the city did not disclose all it knew about air toxicity after 9/11.

French police hunt Renoir thieves after lightning museum heist

French police on Tuesday hunted for two thieves who escaped with two Renoir paintings from a museum, after abandoning two others as they fled, in a burglary that reignited concerns about the protection of France's cultural heritage.

Argentina files lawsuit against oil firms operating off Falklands

Argentina has announced legal action against companies with links to an Israeli-British oil project near the Falkland Islands, as Buenos Aires escalates its claim over the disputed territory.

Trial opens in France over deadliest Channel migrant crossing disaster

Fourteen people suspected of links to trafficking networks went on trial in France on Tuesday over the loss of at least 31 people including a seven-year-old child in the Channel in 2021, the deadliest accident involving asylum seekers trying to reach the English coast.

Flights resume gradually in Indonesia after volcanic eruption

Major airports in Indonesia reopened on Tuesday days after a volcanic eruption had grounded flights, with authorities saying normal operations would resume gradually.

France tries 14 over deadliest Channel migrant crossing disaster

Fourteen people are to go on trial in France on Tuesday over the loss of 31 people including a seven-year-old child in 2021, in the deadliest small-boat crossing accident recorded in the Channel.

'The ber months': Christmas arrives early in the Philippines

At a city block-sized market in the Philippine capital, a platoon of plastic Santa Claus figures parachute from the ceiling of a shop already stacked high with Christmas decor despite the holiday being fully four months away.

Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress

WINNIPEG, MB / ACCESS Newswire / September 8, 2026 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that the design, rationale and baseline data from its MEND-PNPO Phase 3 study (ClinicalTrials.gov NCT04706013) are being presented at the 16th European Epilepsy Congress (EEC), taking place September 5-9, 2026, at the Megaron Athens International Conference Centre in Athens, Greece. MEND-PNPO is a pivotal trial evaluating MC-1 for the treatment of Pyridox(am)ine 5'-Phosphate Oxidase (PNPO) deficiency.

CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework

Legislation delays implementation of new federal hemp restrictions until December 11, 2026, preserving continued access to naturally derived hemp products

Protagonist Therapeutics Announces $300 Million Share Repurchase Program

NEWARK, CA / ACCESS Newswire / September 8, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $300 million of its outstanding common stock.

Appeals Court to Rule Soon on Marijuana Rescheduling as Billions in Cannabis Tax Benefits Hang in the Balance

As the D.C. Circuit prepares to decide whether the Justice Department lawfully moved state marijuana into DEA Schedule 3, experts warn that billions in anticipated tax benefits could unravel.

Who is the Best Cosmetic Surgeon in Washington State?

The Best Cosmetic Surgeon in Washington State is Dr. Sajan as Featured in Seattle Magazine and Seattle Met.

Who is the Best Facelift Surgeon in Seattle?

The Best Facelift Surgeon in Seattle is Dr. Santos at Seattle Plastic Surgery

Arizona Tribune - Boulevard (English)